SEP 22, 2015 11:37 AM PDT

Cancer-Suppressing Gene

Researchers at the University of Adelaide in Australia have discovered the role played by a gene that suppresses the development of cancer. Their work, which was published in the journal PLOS One and reported in Drug Discovery & Development, offers a variety of new opportunities for scientists to develop treatments for cancer. At the crux of the research is the activity of the gene WWOX.
Protein in gene can suppress cancer by altering metabolism. 
According to Professor Rob Richards, Head of Genetics and Evolution in the University’s School of Biological Sciences, “We’ve known for some time that in certain types of cancer, people with low levels of WWOX protein are more likely to develop cancer. We also know that cancers with low levels of WWOX tend to be more aggressive and less responsive to treatment. A higher level of WWOX activity is definitely a good thing to have, but, until now, the role that WWOX plays in cancer suppression has been a mystery.”
 
Working with his team of researchers, Dr Louise O’Keefe and Ph.D. students Amanda Choo and Cheng Shoou Lee, Professor Richards studied the impact of lower levels of WWOX on cells using a genetic model: the small laboratory fly, Drosophila. As Professor Richards explained, “Our research has shown that cancer cells with lower levels of WWOX had a competitive advantage over those cells with normal WWOX levels, and could outgrow them. This could lead to a more aggressive cancer and worse outcomes for cancer patients: poorer survival rates.”
 
After additional research, the scientists saw that the WWOX gene plays a role in the altered metabolism of cancer cells that are known to use glucose differently from normal cells. Cancer cells are likely to use glucose to create more cell building blocks than energy, and this process is what is assumed to help them to divide and grow. 
 
Professor Richards added, “Another set of Drosophila experiments revealed that the WWOX gene helps keep the balance of glucose use in favour of producing energy rather than helping cancer cells multiply. This difference in metabolism is a key part of how cancer cells have a competitive advantage over normal cells. Low WWOX levels will allow more glucose to be used for these cancer cell building blocks.”
 
The research offered good news: is that WWOX belongs to a family of proteins that have enzyme activity. Thus, WWOX activity can be altered by targeting the enzyme.
 
“We now have a good idea of what WWOX does in cancer cells and how it acts to help suppress cancer. And we have a potential target to be able to influence that activity to change the properties of cancer cells,” Professor Richards concluded.
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
MAY 30, 2018
Cannabis Sciences
MAY 30, 2018
Cannabinoid Receptor Role in Inhibition of Renal Cell Carcinoma
Researchers investigated the potential connections between the endocannabinoid system and tumor cell growth inhibition in renal cell carcinoma....
JUN 25, 2018
Cancer
JUN 25, 2018
B-cell Lymphoma Develops After MPN JAK1/2 Therapy
Patients with myeloproliferative neoplasms treated with JAK1/2 inhibitor therapy are at increased risk of developing aggressive B-cell lymphoma due to pre-existing B-cell clone specifically a...
JUL 03, 2018
Cancer
JUL 03, 2018
Hereditary Myeloid Neoplasm Predisposition
New changes in myeloid classification help to outline a new category of AML which develops as a result of hereditary mutations predisposing family members to myeloid neoplasms in adulthood....
JUL 17, 2018
Health & Medicine
JUL 17, 2018
Can the Keto Diet Make Cancer Treatment More Effective?
It’s been said that “you are what you eat” but with so many diet plans and trends, it can be hard to choose. Paleo, keto, Mediterranean,...
SEP 04, 2018
Cancer
SEP 04, 2018
Glyphosate "herbicides" as a carcinogen
You may have heard of glyphosate as it is a chemical that is approved to be used in herbicides. But did you know that it could lead to cancer!!...
SEP 26, 2018
Cancer
SEP 26, 2018
Rare Cancer the Focus of Mesothelioma Awareness Day
More than 2,500 Americans are diagnosed with mesothelioma cancer each year. The cancer is rare but very serious - most patients diagnosed with the disease live just a short 12 to 21 months....
Loading Comments...